-
Taxonomy & unit
-
ifrs-full: AUD
-
Summary
-
Telix Pharmaceuticals Ltd quarterly Liabilities history and growth rate from Q4 2023 to Q4 2024.
- Telix Pharmaceuticals Ltd Liabilities for the quarter ending December 31, 2024 was AUD948M, a 269% increase year-over-year.
Liabilities, Quarterly (AUD)
Liabilities, YoY Quarterly Growth (%)